US Patent Issued to QYUNS THERAPEUTICS on May 13 for "Monoclonal antibodies against human interleukin-4 receptor alpha, encoding nucleic acids thereof and method of use thereof to treat IL-4 or IL-4/IL-13-mediated diseases" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,280, issued on May 13, was assigned to QYUNS THERAPEUTICS Co. LTD. (Jiangsu, China).

"Monoclonal antibodies against human interleukin-4 receptor alpha, encoding nucleic acids thereof and method of use thereof to treat IL-4 or IL-4/IL-13-mediated diseases" was invented by Jiwan Qiu (Jiangsu, China), Wei Chen (Jiangsu, China), Zhihua Qiu (Jiangsu, China), Huaiyao Qiao (Jiangsu, China) and Yiliang Wu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies and fragments against human interleukin-4 receptor alpha (hIL-4RAlpha) and uses thereof. The antibodies and fragments preferably have heavy chain complementary determini...